Accessibility: Skip TopNav
Mark Shearman
Editas Medicine announced that it named Mark Shearman as the Company's Executive Vice President and Chief Scientific Officer.
Format
JPEG
Quelle:
Editas Medicine, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein